Nerve Biologic Products Market –
Regional Analysis
On the basis of region, the
global Nerve
Biologic Products Market is segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa.
Nerve biologic products include
artificial nerve conduit, nerve graft, nerve wraps, or nerve capping devices
used for guiding axonal regrowth to facilitate nerve regeneration. These
devices are majorly used in clinical treatments for nerve injuries. Nerve
biologic products are commonly used for complex suturing, for instance suturing
of two ends of a separated nerve that needs rigid process. The scaffold
material used for generating nerve biologic products is either from synthetic
or biological origin. The nerve biologic products are manufactured from various
biocompatible products such as polysialic acid (PSA), collagen type I/III,
spider silk fiber, silkworm silk fibroin, chitosan, aragonite, and alginate.
Nerve Biologic Products Market
Drivers
Advancements in research and
development for developing innovative technology for nerve biologic products
are expected to drive growth of the nerve biologic product market. For
instance, in February 2015, researchers from the University of Sheffield
developed a device, 3D-printed nerve guidance conduit (NGC). NGC is a network
of miniature tubes, which guide injured nerve ends towards each other, thereby
enabling them to repair naturally. The device uses computer-aided design (CAD),
which can be modified for any type of nerve damage or even adapted for joint
specific nerves of patient.
Furthermore, in June 2016,
Polyganics, a medical device manufacturing company, received the CE mark for
Neurocap, its nerve capping device. Neurocap is an absorbable implant for
treatment and reduction of symptomatic neuroma in peripheral nerves. The device
was cleared for sales in the U.S. in January 2016.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2265
Moreover, U.S. Food and Drug
Administration’s (USFDA) clearances for nerve biologic products is projected to
increase growth of the market. For instance, in June 2014, Collagen Matrix Inc.
received USFDA clearance for its Flexible Collagen Nerve Conduit. Flexible
Collagen Nerve Conduit is a resorbable and flexible type I collagen tubular
matrix that offers encasement for peripheral nerve injuries as well as shielding
of the neural environment.
Furthermore, in May 2015, AxoGen,
Inc. received USFDA clearance to proceed for Investigational New Drug (IND)
application for Avance Nerve Graft. The product is commercially available while
it is transitioned to a biologic product due to USFDA’s enforcement discretion
grant. It has porcine submucosa extracellular matrix used to wrap and protect
injured peripheral nerves and strengthen the nerve reconstruction while preventing
soft tissue attachments.
Nerve Biologic Products Market
Restraint
Product recall by the USFDA due
to contaminations and sterility issues is expected to restrain growth of the
nerve biologic products market. For instance, in June 2015, USFDA recalled
NeuraWrap Nerve Protector and Dural Graft Matrix, manufactured by Integra
LifeSciences, due to process deviation in manufacturing, and higher levels of
pyrogens than acceptable by the specifications for the products. NeuraWrap
Nerve Protector was specified for management of peripheral nerve injuries while
Dural Graft Matrix was an absorbable implant for repair of dural defects.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/nerve-biologic-products-market-2265
Based on region, North America is
expected to hold lead position in the global nerve biologic products market
during the forecast period, owing to rising number of peripheral nerve injuries
in the U.S. For instance, according to Proceedings of the National Academy of
Sciences of the U.S. study in June 2017, over 250,000 people from the U.S.
suffers from peripheral nerve injury annually.
Asia Pacific and Europe region is
also expected to observe significant growth in the nerve biologic products market.
This is attributed to rising awareness of central nervous system disorders and
therapeutic treatments through organized conferences. For instance, proceeding
to 6th International Conference on Central Nervous System (CNS) Disorder and
Therapeutics which is to be held in Paris in November 2018, 7th International
Conference on Central Nervous System (CNS) Disorder and Therapeutics is to be
held in Japan in June 2019. These conferences mainly discusses on topics such
as diseases and disorders of the CNS, neuroimmunological disorders,
neurometabolic disorders, brain tumors, and neurosurgery.
Key players operating in the
global nerve biologic products market include, Stryker, AxoGen, Inc., Integra
LifeSciences, Collagen Matrix, Inc., Polyganics, Checkpoint Surgical Inc., and
TEXAS PHARMACUETICAL PVT LTD.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2265
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment